Celgene Sues To Block Dr. Reddy's Revlimid Generic
Celgene Corp. on Thursday tried to block Dr. Reddy's Laboratories Ltd. from making and selling a generic version of its blockbuster chemotherapy drug Revlimid, accusing the Indian drugmaker in New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article